Delivery Order SPE2DB24D1205-SPE2DB25FCUZQ
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, a specialty medication, with a ceiling value of $2,270.35 and a completion date of April 3, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REMIFENTANIL 2 MG VIALS, a pharmaceutical product, and has a firm fixed price ceiling value of $4,540.75. The contract has an ultimate completion date of April 2, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REMIFENTANIL 1 MG VIALS. The contract has a ceiling value of $3,667.30 and is a firm-fixed price contract with a completion date of June 24, 2025. The contract is not set-aside and was awarded on June 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, with a ceiling value of $11,351.75 and a performance period extending through June 13, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, a prescription medication. The contract has a firm fixed price, a ceiling value of $9,989.54, and an ultimate completion date of June 26, 2025. This delivery order is not set aside for any specific business type. Amerisourcebergen Drug Corp holds...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REMIFENTANIL 1 MG VIALS. The contract has a ceiling value of $2,103.90 and is set to expire on July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2 mg vials of the medication Remifentanil, with a ceiling value of $1,676.23 and a period of performance through July 1, 2025. The contract is a firm fixed-price, non-set-aside award, meaning it was open to full and open competition. AmerisourceBergen Drug Corporation...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on May 12, 2025. The contract has a ceiling value of $1,075.15 and is for the delivery of REMIFENTANIL 2 MG VIALS. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REMIFENTANIL 1 MG VIALS, a medication used for pain management. The contract has a ceiling value of $1,784.70 and a period of performance through June 18, 2025. There is no set-aside designation for this contract, indicating it was competitively awarded....
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, with a ceiling value of $3,667.30 and a period of performance through May 22, 2025. The contract is not set aside and was awarded on May 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCUZQDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 2 MG VIALS, a specialty medication, with a ceiling value of $1,196.54 and a period of performance through March 19, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is likely a task order issued under that broader IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/18/25 |